Online

Enables proteome-wide discovery of O-glycan sites using ‘bottom-up’ ETD-based mass spectrometric analysis. GlycoDomain Viewer is a genetic engineering approach that uses human cell lines to simplify O-glycosylation (SimpleCells). The method was implemented on 12 human cell lines from different organs. It presents a first map of the human O-glycoproteome with almost 3000 glycosites in over 600 O-glycoproteins as well as an improved NetOGlyc4.0 model for prediction of O-glycosylation.

User report

0 user reviews

0 user reviews

No review has been posted.

GlycoDomain Viewer forum

No open topic.

GlycoDomain Viewer classification

GlycoDomain Viewer specifications

Software type:
Package
Restrictions to use:
None
Stability:
Stable
Interface:
Web user interface
Computer skills:
Basic

GlycoDomain Viewer support

Documentation

Credits

Publications

  • (Steentoft et al., 2013) Precision mapping of the human O‐GalNAc glycoproteome through SimpleCell technology. The EMBO Journal.
    DOI: 10.1038/emboj.2013.79

Institution(s)

Copenhagen Center for Glycomics, Departments of Cellular and Molecular Medicine and School of Dentistry, University of Copenhagen, Copenhagen, Denmark; Center for Biological Sequence Analysis, Department of Systems Biology Technical University of Denmark, Lyngby, Denmark; IPATIMUP, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Hørsholm, Denmark; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark

Funding source(s)

This work was supported by Kirsten og Freddy Johansen Fonden, A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til Almene Formaal, The Carlsberg Foundation, The Novo Nordisk Foundation, The Danish Research Councils, a programme of excellence from the University of Copenhagen, the Sino-Danish Breast Cancer Centre, and The Danish National Research Foundation (DNRF107).

Link to literature

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.